Vertex Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 08/12/2026 | 26.12 M | $12.97 B | 2.94% | 10.29% |
| BLACKROCK, INC. | 08/07/2026 | 24.11 M | $11.98 B | 0.58% | 9.50% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 08/12/2026 | 19.49 M | $9.68 B | -7.74% | 7.68% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 16.58 M | $8.24 B | 0.41% | 6.53% |
| STATE STREET CORP | 08/07/2026 | 11.87 M | $5.90 B | 1.20% | 4.68% |
| INVESCO LTD. | 08/14/2026 | 8.04 M | $4.00 B | 50.86% | 3.17% |
| JPMORGAN CHASE & CO | 08/12/2026 | 6.52 M | $3.26 B | -7.33% | 2.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 6.02 M | $2.98 B | -1.98% | 2.37% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 4.88 M | $2.42 B | -5.18% | 1.92% |
| CAPITAL INTERNATIONAL INVESTORS | 08/12/2026 | 4.70 M | $2.33 B | -8.41% | 1.85% |
| LOOMIS SAYLES & CO L P | 08/14/2026 | 3.92 M | $1.95 B | -2.07% | 1.54% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 3.35 M | $1.66 B | 507.34% | 1.32% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 3.25 M | $1.61 B | 1.09% | 1.28% |
| MORGAN STANLEY | 08/13/2026 | 3.24 M | $1.61 B | 1.67% | 1.28% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 3.09 M | $1.53 B | 0.96% | 1.22% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 3.04 M | $1.51 B | 5.59% | 1.20% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2026 | 3.02 M | $1.35 B | -22.80% | 1.19% |
| JENNISON ASSOCIATES LLC | 08/03/2026 | 3.00 M | $1.49 B | 9.43% | 1.18% |
| NORGES BANK | 08/12/2026 | 2.97 M | $1.48 B | 100.00% | 1.17% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 2.60 M | $1.29 B | -1.09% | 1.03% |
| NORTHERN TRUST CORP | 08/13/2026 | 2.49 M | $1.24 B | -3.03% | 0.98% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 2.48 M | $1.23 B | 2.64% | 0.98% |
| CLEARBRIDGE INVESTMENTS, LLC | 08/13/2026 | 2.34 M | $1.16 B | -13.26% | 0.92% |
| VICTORY CAPITAL MANAGEMENT INC | 08/07/2026 | 2.17 M | $1.08 B | 15.07% | 0.86% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 2.04 M | $1.01 B | 6.27% | 0.80% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 2.04 M | $1.01 B | 100.00% | 0.80% |
| LEGAL & GENERAL GROUP PLC | 08/14/2026 | 1.87 M | $928.89 M | -4.38% | 0.74% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.73 M | $858.56 M | -1.80% | 0.68% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 1.67 M | $830.84 M | 5.43% | 0.66% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 1.58 M | $784.39 M | 2.69% | 0.62% |
| AMUNDI | 08/11/2026 | 1.55 M | $768.20 M | 5.03% | 0.61% |
| FMR LLC | 08/13/2026 | 1.46 M | $723.81 M | -27.87% | 0.57% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.43 M | $708.03 M | -2.75% | 0.56% |
| JUPITER TOPCO LLC | 08/14/2026 | 1.26 M | $625.80 M | 100.00% | 0.50% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.17 M | $580.70 M | 18.15% | 0.46% |
| WCM INVESTMENT MANAGEMENT, LLC | 08/13/2026 | 1.15 M | $575.64 M | 2.74% | 0.45% |
| NUVEEN, LLC | 08/11/2026 | 1.08 M | $537.30 M | -0.26% | 0.43% |
| ROYAL BANK OF CANADA | 08/14/2026 | 980.26 K | $486.92 M | -11.84% | 0.39% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 897.89 K | $446.04 M | 5.88% | 0.35% |
| ASSENAGON ASSET MANAGEMENT S.A. | 08/21/2026 | 759.56 K | $377.30 M | 41.38% | 0.30% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 749.53 K | $372.31 M | 0.61% | 0.30% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 08/13/2026 | 738.38 K | $366.77 M | 15.56% | 0.29% |
| BARCLAYS PLC | 08/14/2026 | 733.27 K | $364.24 M | 10.56% | 0.29% |
| SWISS NATIONAL BANK | 08/11/2026 | 717.44 K | $356.37 M | -3.65% | 0.28% |
| UBS GROUP AG | 08/13/2026 | 712.26 K | $353.80 M | 12.95% | 0.28% |
| CITIGROUP INC | 08/03/2026 | 706.97 K | $351.17 M | 3.54% | 0.28% |
| HSBC HOLDINGS PLC | 08/14/2026 | 676.25 K | $335.81 M | 3.17% | 0.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 674.30 K | $334.95 M | 20.17% | 0.27% |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 08/07/2026 | 647.19 K | $321.48 M | 8.32% | 0.25% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 616.17 K | $305.00 M | 260.27% | 0.24% |
Vertex Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 2438 institutional investors and hedge funds held shares of Vertex Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Capital World Investors: 26.12 M
BlackRock, Inc.: 24.11 M
Capital Research Global Investors: 19.49 M
VANGUARD CAPITAL MANAGEMENT LLC: 16.58 M
STATE STREET CORP: 11.87 M
Invesco Ltd.: 8.04 M
95.90% of Vertex Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 334.81 M shares in the last 24 months. This purchase volume represents approximately $154.31 B in transactions.